Rothblatt Martine A
United Therapeutics Corporation · Chairperson & CEO
Rothblatt Martine A is listed in filings as Chairperson & CEO at United Therapeutics Corporation. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity and purchase activity. Recent filings connect the profile to United Therapeutics Corporation (UTHR). The current snapshot covers public activity from May 27, 2026 to Jun 24, 2026. Reported amounts are shown as $146.3K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $146k271 shares | SellJun 22, 2026 | $539.90 | $532.27 | |
| $1M2.7k shares | SellJun 22, 2026 | $539.18 | $532.27 | |
| $2M3.2k shares | SellJun 22, 2026 | $538.29 | $532.27 | |
| $537k1k shares | SellJun 22, 2026 | $537.13 | $532.27 | |
| $607k1.1k shares | SellJun 22, 2026 | $536.02 | $532.27 | |
| $532k995 shares | SellJun 22, 2026 | $534.94 | $532.27 | |
| $124k232 shares | SellJun 22, 2026 | $534.09 | $532.27 |